Story Health Raises $4M for Specialty Care Clinical Decision Tool

Story Health, a developer of virtualized specialty care solutions, raised $4 million in seed funding from General Catalyst and Define Ventures.

According to Story Health, the solution helps specialty clinicians understand each medical situation and make clinical decisions at scale through virtual protocols.

The solution goes beyond video visits to guide and adapt to a patient’s needs on a day-by-day basis through optimizing care plans, understanding therapy efficacy, and suggesting evidence-based changes, the company said in a statement.

“Critical opportunities to optimize care are often lost in the months between clinic visits. We empower specialists to use virtual care to close the gap between clinical evidence and patient reality,” said Story Health founder Tom Stanis.

“The potential of virtual care is massive, yet still largely untapped. We launched Story Health to create what we call adaptive virtualized care – a system that empowers specialists to achieve medical goals with patients beyond the clinic by adapting to real-world scenarios. We give virtual superpowers to specialists.”

The company plans to use the seed funds to create more partnerships with clinicians, grow its product offering, and expand the ways it maximizes specialty care.

“Significant businesses are being built around better access and customer-first, data-driven experiences across every aspect of healthcare,” said Hemant Taneja, Managing Director at General Catalyst. “Tom, Nikhil, and Ashul are working towards exactly that for specialized care with Story Health. We’re excited to partner with them as they address this important need.”

Clinical Decision Support software companies raised $660 million in the first nine months of 2020, according to Mercom’s latest report. More recently, Congenica, a clinical treatment decision platform, announced the completion of its Series C funding round, raising $50 million. The funding round was co-led by Tencent and Legal & General and included other new investors.